We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AD
3751
Array Digital Infrastructure
AD
$3.06B
| $474K | ﹤0.01% |
13,265
-8,538
| -39% | -$317K |
|
3752
OptimizeRx
OPRX
$129M
| $473K | ﹤0.01% |
+7,623
| New | +$388K |
|
|
AAC
3753
DELISTED
Ares Acquisition Corporation
AAC
| $469K | ﹤0.01% |
+48,000
| New | +$471K |
|
3754
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.6M
| $468K | ﹤0.01% |
6,280
+380
| +6% | +$29.1K |
|
3755
Anterix
ATEX
$2.07B
| $467K | ﹤0.01% |
7,763
-666
| -8% | -$33.4K |
|
3756
Rhythm Pharmaceuticals
RYTM
$7.26B
| $467K | ﹤0.01% |
23,802
-1,654
| -6% | -$34.3K |
|
|
CTT
3757
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $465K | ﹤0.01% |
39,847
-7,265
| -15% | -$84.4K |
|
3758
iShares MSCI Switzerland ETF
EWL
$2.21B
| $464K | ﹤0.01% |
9,547
+2,908
| +44% | +$139K |
|
3759
ProShares Ultra FTSE Europe
UPV
$14.3M
| $463K | ﹤0.01% |
6,854
-914
| -12% | -$61.4K |
|
3760
Community Trust Bancorp
CTBI
$1.44B
| $462K | ﹤0.01% |
11,466
-5,793
| -34% | -$254K |
|
3761
CALL
Aflac
AFL
$63.7B
| $461K | ﹤0.01% |
8,600
-26,800
| -76% | -$1.46M |
|
|
IVA
3762
Inventiva
IVA
$1.07B
| $458K | ﹤0.01% |
33,712
+4,376
| +15% | +$62K |
|
3763
Rigel Pharmaceuticals
RIGL
$716M
| $458K | ﹤0.01% |
10,529
-5,853
| -36% | -$221K |
|
|
DCP
3764
DELISTED
DCP Midstream, LP
DCP
| $458K | ﹤0.01% |
15,636
-5,703
| -27% | -$147K |
|
3765
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
| $457K | ﹤0.01% |
3,166
-6,916
| -69% | -$965K |
|
3766
TherapeuticsMD
TXMD
$23.6M
| $457K | ﹤0.01% |
7,682
+2,316
| +43% | +$140K |
|
3767
Aclaris Therapeutics
ACRS
$835M
| $456K | ﹤0.01% |
+25,967
| New | +$590K |
|
3768
United Fire Group
UFCS
$1.38B
| $456K | ﹤0.01% |
16,505
+217
| +1% | +$6.76K |
|
3769
Geron
GERN
$860M
| $455K | ﹤0.01% |
322,974
-17,072
| -5% | -$24.8K |
|
|
VLRS
3770
Controladora Vuela Compania de Aviacion
VLRS
$954M
| $455K | ﹤0.01% |
24,344
-13,618
| -36% | -$232K |
|
3771
Lands' End
LE
$395M
| $453K | ﹤0.01% |
11,029
-5,584
| -34% | -$152K |
|
|
SP
3772
DELISTED
SP Plus Corporation
SP
| $452K | ﹤0.01% |
14,777
-37
| -0.2% | -$1.21K |
|
3773
Cheniere Energy
CQP
$31.9B
| $449K | ﹤0.01% |
10,134
-1,218
| -11% | -$51.2K |
|
3774
Personalis
PSNL
$1.44B
| $449K | ﹤0.01% |
17,734
+1,086
| +7% | +$24.9K |
|
3775
Forrester Research
FORR
$228M
| $448K | ﹤0.01% |
9,786
-2,406
| -20% | -$104K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.